Impact of Traditional Chinese Medicine on Breast Cancer Patients' Vital Energy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of a Traditional Chinese Medicine (TCM) therapy program aimed at reinforcing vital energy in breast cancer patients undergoing conventional treatments. Participants will engage in TCM supportive therapy courses and receive educational and psychological support to enhance their quality of life. The study employs international standard questionnaires to assess the impact on patients' physical, emotional, spiritual, and social well-being. The goal is to determine if TCM can alleviate symptoms and improve overall satisfaction with cancer care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study.
* Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine.
* Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy.

Exclusion Criteria:

* Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine.
* Patients regularly receiving Astragalus polysaccharide injections.
* Patients with a history of allergies to Traditional Chinese Medicine.
* Pregnant or breastfeeding women.
* Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs.
* Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form).

Where it's running

• Taipei City Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Study coordinator: Yu-Hsuan Tai, MD
• Email: daidayangisele@gmail.com, DBB02@tpech.gov.tw
• Phone: +886918130891

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HTR2 CAR T Cells Targeting HER2 in Metastatic Breast Cancer

  A one-time treatment with specially modified T cells that target HER2-positive metastatic breast cancer is tested to see if it’s safe and how long the cells last, with a plan for possible dose increases.

  Recruiting Phase 1 Baylor College of Medicine · Houston, Texas · NCT06251544

• Using Sacubitril/Valsartan to prevent heart damage in breast cancer treatment

  This study is testing if the medication Sacubitril/Valsartan can help protect the hearts of women undergoing treatment for breast cancer from damage.

  Recruiting at 3 sites Phase 4 Silesian Centre for Heart Diseases · Opole, Opole Voivodeship and 3 other locations · NCT05465031

• Evaluating axillary treatment options for breast cancer patients after chemotherapy

  This study is testing if early stage breast cancer patients can skip extra treatments for their underarm area after chemotherapy if their lymph nodes show no signs of cancer.

  Recruiting at 95 sites University Hospitals of Derby and Burton NHS Foundation Trust · Dublin and 97 other locations · NCT04109079

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.